Double Blind Efficacy and Safety Study of Flexible-Dose vs Low-Dose Q8003 After Undergoing Primary Unilateral Total Knee Arthroplasty

Clinical trial NCT01055015 · COMPLETED

Trial details

NCT number: NCT01055015
Sponsor: QRxPharma Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Postoperative Pain

Start date: 2010-02-01
Primary completion: 2010-12-01
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.